Fintel reports that on October 5, 2023, RBC Capital maintained coverage of Hologic (NASDAQ:HOLX) with a Sector Perform recommendation.
Analyst Price Forecast Suggests 31.47% Upside
As of October 5, 2023, the average one-year price target for Hologic is 90.94. The forecasts range from a low of 75.75 to a high of $99.75. The average price target represents an increase of 31.47% from its latest reported closing price of 69.17.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Hologic is 4,166MM, an increase of 3.16%. The projected annual non-GAAP EPS is 4.00.
What is the Fund Sentiment?
There are 1514 funds or institutions reporting positions in Hologic. This is a decrease of 25 owner(s) or 1.62% in the last quarter. Average portfolio weight of all funds dedicated to HOLX is 0.27%, a decrease of 4.01%. Total shares owned by institutions decreased in the last three months by 2.45% to 262,784K shares. 
The put/call ratio of HOLX is 0.55, indicating a bullish outlook.
What are Other Shareholders Doing?
T. Rowe Price Investment Management holds 21,937K shares representing 8.96% ownership of the company. In it's prior filing, the firm reported owning 21,841K shares, representing an increase of 0.44%. The firm decreased its portfolio allocation in HOLX by 4.26% over the last quarter.
RPMGX - T. Rowe Price Mid-Cap Growth Fund holds 10,741K shares representing 4.39% ownership of the company. In it's prior filing, the firm reported owning 10,748K shares, representing a decrease of 0.06%. The firm decreased its portfolio allocation in HOLX by 3.43% over the last quarter.
Wellington Management Group Llp holds 9,605K shares representing 3.92% ownership of the company. In it's prior filing, the firm reported owning 8,985K shares, representing an increase of 6.45%. The firm increased its portfolio allocation in HOLX by 626.97% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 7,691K shares representing 3.14% ownership of the company. In it's prior filing, the firm reported owning 7,630K shares, representing an increase of 0.79%. The firm decreased its portfolio allocation in HOLX by 6.69% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 5,858K shares representing 2.39% ownership of the company. In it's prior filing, the firm reported owning 5,750K shares, representing an increase of 1.84%. The firm decreased its portfolio allocation in HOLX by 7.43% over the last quarter.
Hologic Background Information
(This description is provided by the company.)
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
